ARCHIVES

Drug Approvals; Zykadia Granted Accelerated Approval For ALK+ NSCLC; ADXS-HPV Grated Orphan Drug Designation

This article is from The Cancer Letter archive.

Vol. 40 No. 19 | May 9, 2014

Download PDF Visit The Full Archive

Related Articles

U.S. Patients Use More Chemotherapy, Less Emergency Care than Canadians

May 27, 2011

Troubled Allegheny Cuts Cancer Programs; Institution Holds Grants for NSABP, ECOG

July 10, 1998

In congress: Senate Committee Approves 7.5 Percent Increase for NIH

July 25, 1997

NCI CTEP Approved Trials For the Month of December

December 27, 2013

GOP Sweep Takes Out Two Old Friends, But Reagan Spoken say He Supports Cancer Program, NIH

November 14, 1980

“Wild West” of Molecular Testing?: Caris Engaged in Aggressive Marketing, Improper Medicare Billing, Lawsuit Alleges

August 8, 2014